Page last updated: 2024-10-26

valproic acid and Congenital Hyperinsulinism

valproic acid has been researched along with Congenital Hyperinsulinism in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Congenital Hyperinsulinism: A familial, nontransient HYPOGLYCEMIA with defects in negative feedback of GLUCOSE-regulated INSULIN release. Clinical phenotypes include HYPOGLYCEMIA; HYPERINSULINEMIA; SEIZURES; COMA; and often large BIRTH WEIGHT. Several sub-types exist with the most common, type 1, associated with mutations on an ATP-BINDING CASSETTE TRANSPORTERS (subfamily C, member 8).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de las Heras, J1
Garin, I1
de Nanclares, GP1
Aguayo, A1
Rica, I1
CastaƱo, L1
Vela, A1

Other Studies

1 other study available for valproic acid and Congenital Hyperinsulinism

ArticleYear
Familial hyperinsulinism-hyperammonemia syndrome in a family with seizures: case report.
    Journal of pediatric endocrinology & metabolism : JPEM, 2010, Volume: 23, Issue:8

    Topics: Adult; Anticonvulsants; Child, Preschool; Congenital Hyperinsulinism; Family Health; Female; Glutama

2010